Evidence map›Paper›PMID 26884207›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells.

Salah Mansour, Anna S Tocheva, Chris Cave-Ayland, Moritz M Machelett, Barbara Sander, Nikolai M Lissin, Peter E Molloy, Mark S Baird, Gunthard Stübs, Nicolas W J Schröder and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Detergents alter the stability and lipid binding properties of the CD1d immunoreceptor.Protein science : a publication of the Protein Society · 2026
    Article
  4. Article
  5. Sideways lipid presentation by the antigen-presenting molecule CD1c.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Insights into the CD1 lipidome.Frontiers in immunology · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Novel Molecular Insights into Human Lipid-Mediated T Cell Immunity.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Reconsidering the Optimal Immune Response toAmerican journal of respiratory and critical care medicine · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 3 countries.

Salah MansourClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; sgadola@gmail.com s.mansour@soton.ac.uk.
Anna S TochevaClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Chris Cave-AylandSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Moritz M MachelettInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; Centre for Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Barbara SanderSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Nikolai M LissinImmunocore Limited, Abingdon, Oxon OX14 4RY, United Kingdom;
Peter E MolloyImmunocore Limited, Abingdon, Oxon OX14 4RY, United Kingdom;
Mark S BairdSchool of Chemistry, Bangor University, Bangor, Gwynedd LL57 2DG, United Kingdom;
Gunthard StübsInstitute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany;
Nicolas W J SchröderInstitute for Pathology, Otto-von-Guericke University Magdeburg, 39106 Magdeburg, Germany;
Ralf R SchumannInstitute for Microbiology and Hygiene, Charité University Medical Center, 10117 Berlin, Germany;
Jörg RademannDivision of Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany;
Anthony D PostleClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Bent K JakobsenImmunocore Limited, Abingdon, Oxon OX14 4RY, United Kingdom;
Ben G MarshallClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Rajendra GosainSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Paul T ElkingtonClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Tim ElliottInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Chris-Kriton SkylarisInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; School of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Jonathan W EssexInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; School of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Ivo TewsInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; Centre for Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;
Stephan D GadolaClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; Novartis Institutes of Biomedical Research, 4058 Basel, Switzerland sgadola@gmail.com s.mansour@soton.ac.uk.
University of Southampton · GBImmunocore (United Kingdom) · GBBangor University · GBCharité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DENovartis Institutes for BioMedical ResearchOtto-von-Guericke University Magdeburg · DEUniversitätsmedizin Greifswald · DE

Funding

Biotechnology and Biological Sciences Research Council BB/J017302/1Cancer Research UK 16997
6 · The paper itself

Abstract

Cluster of differentiation 1c (CD1c)-dependent self-reactive T cells are abundant in human blood, but self-antigens presented by CD1c to the T-cell receptors of these cells are poorly understood. Here we present a crystal structure of CD1c determined at 2.4 Å revealing an extended ligand binding potential of the antigen groove and a substantially different conformation compared with known CD1c structures. Computational simulations exploring different occupancy states of the groove reenacted these different CD1c conformations and suggested cholesteryl esters (CE) and acylated steryl glycosides (ASG) as new ligand classes for CD1c. Confirming this, we show that binding of CE and ASG to CD1c enables the binding of human CD1c self-reactive T-cell receptors. Hence, human CD1c adopts different conformations dependent on ligand occupancy of its groove, with CE and ASG stabilizing CD1c conformations that provide a footprint for binding of CD1c self-reactive T-cell receptors.

Indexed as

Antigens, CD1Antigens, CD1dCholesterol EstersGlycoproteinsHumansMolecular Dynamics SimulationProtein ConformationT-LymphocytesAntigens, CD1Antigens, CD1dCD1C protein, humanCholesterol EstersGlycoproteinsantigen presentationCD1cholesteryl esterlipid antigenT cell

Identifiers

PMID26884207
PMCPMC4780616
OpenAlexW2280128469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.